<DOC>
	<DOCNO>NCT00481195</DOCNO>
	<brief_summary>The primary objective study determine armodafinil treatment , dosage 150 mg/day , effective placebo treatment adjunctive therapy adult experience major depressive episode associate Bipolar I Disorder inadequately responsive current treatment current major depressive episode .</brief_summary>
	<brief_title>Armodafinil Treatment Adjunctive Therapy Adults With Major Depression Associated With Bipolar I Disorder</brief_title>
	<detailed_description />
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Armodafinil</mesh_term>
	<mesh_term>Modafinil</mesh_term>
	<criteria>Key The patient diagnosis Bipolar I Disorder currently experience major depressive episode . The patient currently treat 1 2 follow drug : lithium , olanzapine , valproic acid . Key The patient Axis I disorder apart Bipolar I Disorder primary focus treatment within 6 month screen visit ( exception nicotine dependence ) . The patient clinically significant uncontrolled medical surgical condition . The patient previously receive modafinil armodafinil , patient know sensitivity ingredient study drug tablet . The patient pregnant lactate woman . ( Any woman become pregnant study withdrawn study . )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2013</verification_date>
</DOC>